EP 1001764 A1 20000524 - HETEROCYCLIC AMIDE COMPOUNDS AS CELL ADHESION INHIBITORS
Title (en)
HETEROCYCLIC AMIDE COMPOUNDS AS CELL ADHESION INHIBITORS
Title (de)
HETEROZYKLISCHE AMIDE ALS ZELLADHÄSIONSHEMMERN
Title (fr)
COMPOSES D'AMIDE HETEROCYCLIQUES UTILISES EN TANT QU'INHIBITEURS DE L'ADHESION CELLULAIRE
Publication
Application
Priority
- GB 9714314 A 19970707
- GB 9800686 A 19980114
- US 9810940 W 19980529
- US 4801797 P 19970529
- US 6652597 P 19971125
Abstract (en)
[origin: WO9853814A1] Compounds of formula (I) are antagonists of VLA-4 and/or alpha 4 beta 7, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of asthma, allergies, inflammation, multiple sclerosis, and other inflammatory and autoimmune disorders.
IPC 1-7
C07F 9/02; A61K 31/405; A61K 31/395; A61K 31/41; A61K 31/415; A61K 31/425; A61K 31/435; A61K 31/445
IPC 8 full level
A61K 31/401 (2006.01); A61K 31/445 (2006.01); A61K 38/00 (2006.01); A61P 1/04 (2006.01); A61P 9/10 (2006.01); A61P 11/06 (2006.01); A61P 25/00 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07K 5/06 (2006.01); C07K 5/078 (2006.01)
CPC (source: EP)
A61K 31/401 (2013.01); A61K 31/445 (2013.01); A61K 31/472 (2013.01); A61K 31/4725 (2013.01); A61P 1/04 (2017.12); A61P 9/10 (2017.12); A61P 11/06 (2017.12); A61P 25/00 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07K 5/06139 (2013.01); C07K 5/06165 (2013.01); C07K 5/06191 (2013.01); A61K 38/00 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9853814 A1 19981203; CA 2291778 A1 19981203; EP 1001764 A1 20000524; EP 1001764 A4 20050824; JP 2002512625 A 20020423
DOCDB simple family (application)
US 9810940 W 19980529; CA 2291778 A 19980529; EP 98926122 A 19980529; JP 50093499 A 19980529